March 2025 - Page 2 of 12

FridayMar 28, 2025 1:45 pm

FAVO Capital Inc. (FAVO): Solving the SMB Capital Crisis in a Tighter Lending Environment

SMBs face severe funding challenges, with over 75% of owners worried about securing credit amid rising interest rates and stricter lending practices FAVO Capital’s platform in development will enable businesses to apply for funding, track progress, and manage repayments, complemented by a mobile app for real-time insights and personalized recommendations FAVO Capital's tailored financial products provide essential support for SMBs, enabling them to scale operations and contribute to economic stability Access to capital has long been the lifeline of small and medium-sized businesses (“SMBs”), but today, that lifeline is fraying. Rising interest rates, stricter lending practices, and ongoing banking instability…

FridayMar 28, 2025 1:00 pm

Adageis Simplifies Value-Based Care for Healthcare Providers

Adageis makes it easier for providers to identify and obtain the most profitable reimbursements while maintaining high-quality value-based care. The company’s platform enables providers to receive the full payments they deserve by advocating on their behalf with insurers. Adageis offers seamless integration – the platform works with over 90 electronic health record (“EHR”) systems, eliminating the need for disruptive system changes. The company is working with investors to develop new solutions to support small and independent healthcare practices. Healthcare providers often struggle with complex reimbursement structures, making it difficult to optimize cash flow while ensuring high-quality value-based patient care. Adageis…

FridayMar 28, 2025 12:15 pm

Brera Holdings PLC (NASDAQ: BREA) Building Grassroots Football Opportunities for Young Athletes

Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs, sees its work with Juve Stabia Academy in Naples as a prime example of how to foster the next generation of football talent In December 2024, the company signed an agreement to acquire a majority ownership stake in SS Juve Stabia srl, currently in playoff position in Italy’s Serie B league Juve Stabia has produced amazing talents such as Luigi Vitale, Raffaele Ametrano, Giovanni Cervone, and Antonio Donnarumma, three of whom have had over 130 Italian Serie A league appearances Brera…

ThursdayMar 27, 2025 3:30 pm

QualityStocksNewsBreaks – Powered by Physics: Newton Golf Company’s (NASDAQ: NWTG) Rebrand Spotlights Game-Changing Technology

Newton Golf (NASDAQ: NWTG) has completed a strategic rebranding to emphasize its commitment to innovation and align more closely with its mission of integrating advanced physics principles into golf-equipment design. The restructuring was not merely a change in name but a reflection of Newton Golf’s dedication to creating equipment that leverages the laws of physics to benefit golfers of all skill levels. Central to the company’s product lineup are the Newton Gravity Putters and Newton Motion Shafts. Renowned for their ultra-low balance point (“ULBP”) technology, the gravity putters promote a smoother, more controlled putting stroke. The innovation has garnered attention on…

ThursdayMar 27, 2025 3:00 pm

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioning at the Forefront of Next-Gen Energy Storage

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is a frontrunner in lithium-sulfur battery innovation through its subsidiary, Lion Battery Technologies. By leveraging the unique properties of platinum and palladium, PLG is improving the efficiency and longevity of these batteries, which offer higher energy density, lower production costs, and environmental benefits compared to traditional lithium-ion batteries. With significant progress made in research, including testing at the Battery Innovation Center and securing key patents, PLG is positioning itself as a leader in next-generation energy storage. Aligned with global demand, PLG’s efforts position the company at the cutting-edge of this exciting technological frontier,…

ThursdayMar 27, 2025 12:35 pm

QualityStocksNewsBreaks – TransCode Therapeutics Inc. (NASDAQ: RNAZ) Secures $10M in Registered Direct Offering

TransCode (NASDAQ: RNAZ), the oncology company committed to utilizing RNA therapeutics to more effectively treat cancer, has announced the closing of its sale of 10,250,000 shares of its common stock and warrants to purchase up to 10,250,000 shares of common stock priced at-the-market under Nasdaq rules, at a purchase price of $0.98 per share and accompanying warrant. The company secured approximately $10 million in gross proceeds from the offering. TransCode intends to use the proceeds primarily for product development activities, including one or more clinical trials with its lead therapeutic candidate, TTX-MC138, including related IND-enabling studies, as well as for…

ThursdayMar 27, 2025 11:32 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Posts $107.5 Million in 2024 Revenue, Eyes AI Product Expansion

Massimo Group (NASDAQ: MAMO), reported $107.5 million in revenue for fiscal 2024, up 4% from the previous year, driven by expanded UTV, ATV and e-bike sales through large U.S. retailers. The company ended the year with $19.2 million in working capital and a $9.4 million boost in cash. Operational highlights included relocating golf cart production to its Garland, Texas facility, launching a robotic assembly line and enhancing its national distribution network. Looking ahead, Massimo plans to enter the AI space by distributing robotic companions and utility assistants, broadening its reach beyond traditional powersports. To view the full press release, visit https://ibn.fm/gKWyQ …

ThursdayMar 27, 2025 11:10 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Launches Investor Roadshow Highlighting Global Expansion Strategy

Brera Holdings (NASDAQ: BREA), an Ireland-based international sports club operator, has kicked off an investor roadshow in South Florida, with Executive Chairman Daniel McClory and CEO Pierre Galoppi presenting the company’s multi-club ownership ("MCO") strategy and recent growth developments. The sessions, taking place in West Palm Beach and Boca Raton, will showcase Brera’s expansion in both men’s and women’s football and its ongoing pursuit of new acquisitions in emerging markets. The roadshow follows recent momentum in global partnerships and portfolio growth aimed at driving long-term shareholder value. To view the full press release, visit https://ibn.fm/z5rx2 About Brera Holdings PLC Brera…

ThursdayMar 27, 2025 10:00 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell

Scinai Immunotherapeutics (NASDAQ: SCNI), announced it has signed a binding option agreement to acquire Pincell srl, an Italian biotech developing PC111, a first-in-class antibody targeting severe skin blistering disorders. In tandem, Scinai's Polish subsidiary submitted a €12 million non-dilutive grant application under the EU’s FENG program to fund the next development phase of PC111. The agreement positions Scinai to advance treatments for high-mortality conditions like pemphigus and Stevens-Johnson Syndrome without immunosuppression, with Pincell's leadership expected to integrate into Scinai’s expanding European operations. To view the full press release, visit https://ibn.fm/pzUzw About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical company with…

ThursdayMar 27, 2025 9:45 am

Clene Inc.’s (NASDAQ: CLNN) Q1 Virtual Investor Summit Presentation Available for On-Demand Viewing

Clene’s presentation by CEO Rob Etherington and CFO Morgan Brown is now available on demand on the event’s website, covering the company’s recent achievements and immediate plans for lead drug candidate CNM-Au8®. Clene is planning to submit a New Drug Application (“NDA”) to the FDA for potential accelerated approval for CNM-Au8 for ALS in the second half of 2025. The company recently released the latest data from a cross-regimen analysis of HEALEY ALS Platform Trial, showing that CNM-Au8 significantly extends survival in patients with ALS. Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical…

Site Search

Company Search

Month: March 2025